NEW YORK, Oct. 18, 2017 -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed in the United States District Court for the Middle District of Florida on behalf of investors who purchased Tech Data Corporation ("Tech Data" or the “Company”) (NASDAQ:TECD) securities between June 1, 2017 and August 31, 2017, inclusive (“Class Period”).
Investors who have incurred losses in Tech Data Corporation are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action on our website, www.whafh.com.
If you have purchased shares of Tech Data Corporation and would like to assist with the litigation process as a lead plaintiff, you may, no later than November 24, 2017, request that the Court appoint you lead plaintiff of the proposed class.
The filed complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
- the Company was experiencing execution and operational issues;
- these issues were impacting the Company’s financial performance;
- consequently, the Company would not achieve its guidance; and
- therefore, the Company’s financial statements were materially false and misleading at all relevant times.
On August 31, 2017, during a conference call to discuss results for the second fiscal quarter ended July 31, 2017, the Company’s CEO, Robert Dutkowsky, disclosed that the Company was experiencing execution and operational issues that “impacted us in this quarter in a way that was much larger than we anticipated.” Upon the dissemination of this news, shares of Tech Data fell $22.83 per share on August 31, 2017, closing at $87.46, a decline of 20.7% which represented a loss in market capitalization of $870 million.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735, via e-mail at [email protected], or visit our website at www.whafh.com.
## Follow the firm and learn about newly filed cases on Twitter and Facebook. ##
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
Email: [email protected], [email protected] or [email protected]
Tel: (800) 575-0735 or (212) 545-4774
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.


Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 



